Circulating t(14;18)-positive cells in healthy individuals: association with age and sex but not with smoking

References

• Weiss LM, Warnke RA, Sklar J, et al. Molecular analysis of the t(14;18) chromosomal translocation in malignant lymphomas. N Engl J Med 1987;317:1185–1189.
   PubMed Web of Science ®Google Scholar
• Bende RJ, Smit LA, van Noesel CJ. Molecular pathways in follicular lymphoma. Leukemia 2007;21:18–29.
   PubMed Web of Science ®Google Scholar
• Jaffe ES, Harris NL, Stein H, et al. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2008.
   Google Scholar
• Graninger WB, Seto M, Boutain B, et al. Expression of Bcl-2 and Bcl-2-Ig fusion transcripts in normal and neoplastic cells. J Clin Invest 1987;80:1512–1515.
   PubMed Web of Science ®Google Scholar
• Hockenbery D, Nuñez G, Milliman C, et al. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990;348:334–336.
   PubMed Web of Science ®Google Scholar
• Vaux DL, Cory S, Adams JM. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 1988;335:440–442.
   PubMed Web of Science ®Google Scholar
• McDonnell TJ, Deane N, Platt FM, et al. bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell 1989;57:79–88.
   PubMed Web of Science ®Google Scholar
• McDonnell TJ, Korsmeyer SJ. Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18). Nature 1991;349:254–256.
   PubMed Web of Science ®Google Scholar
• Limpens J, De Jong D, Van Krieken JHJM, et al. Bcl-2/JH rearrangements in benign lymphoid tissues with follicular hyperplasia. Oncogene 1991;6:2271–2276.
   PubMed Web of Science ®Google Scholar
• Liu Y, Hernandez AM, Shibata D, et al. BCL2 translocation frequency rises with age in humans. Proc Natl Acad Sci USA 1994;91:8910–8914.
   PubMed Web of Science ®Google Scholar
• Bell DA, Liu Y, Cortopassi GA. Occurrence of bcl-2 oncogene translocation with increased frequency in the peripheral blood of heavy smokers. J Natl Cancer Inst 1995;87:223–224.
   PubMed Web of Science ®Google Scholar
• Ji W, Qu G, Ye P, et al. Frequent detection of bcl-2/JH translocations in human blood and organ samples by a quantitative polymerase chain reaction assay. Cancer Res 1995;55:2876–2882.
   PubMed Web of Science ®Google Scholar
• Dölken G, Illerhaus G, Hirt C, et al. BCL-2/JH-rearrangements in circulating B cells of healthy blood donors and patients with nonmalignant diseases. J Clin Oncol 1996;14:1333–1344.
   PubMed Web of Science ®Google Scholar
• Summers KE, Goff LK, Wilson AG, et al. Frequency of the Bcl-2/IgH rearrangement in normal individuals: implications for the monitoring of disease in patients with follicular lymphoma. J Clin Oncol 2001;19:420–424.
   PubMed Web of Science ®Google Scholar
• Roulland S, Lebailly P, Lecluse Y, et al. Characterization of the t(14;18) BCL2-IGH translocation in farmers occupationally exposed to pesticides. Cancer Res 2004;64:2264–2269.
   PubMed Web of Science ®Google Scholar
• Roulland S, Lebailly P, Lecluse Y, et al. Long-term clonal persistence and evolution of t(14;18)-bearing B cells in healthy individuals. Leukemia 2006;20:158–162.
   PubMed Web of Science ®Google Scholar
• Schüler F, Dölken L, Hirt C, et al. Prevalence and frequency of circulating t(14;18)-MBR translocation carrying cells in healthy individuals. Int J Cancer 2009;124:958–963.
   PubMed Web of Science ®Google Scholar
• John U, Greiner B, Hensel E, et al. Study of Health In Pomerania (SHIP): a health examination survey in an east German region: objectives and design. Soz Praventivmed 2001;46:186–194.
   PubMedGoogle Scholar
• Dölken L, Schüler F, Dölken G. Quantitative detection of t(14;18)-positive cells by real-time quantitative PCR using fluorogenic probes. BioTechniques 1998;25:1058–1064.
   PubMed Web of Science ®Google Scholar
• Fuscoe JC, Setzer RW, Collard DD, et al. Quantification of t(14;18) in the lymphocytes of healthy adult humans as a possible biomarker for enviromental exposure to carcinogens. Carcinogenesis 1996;17: 1013–1020.
   PubMed Web of Science ®Google Scholar
• Rauzy O, Galoin S, Chale JJ, et al. Detection of t(14;18) carrying cells in bone marrow and peripheral blood from patients affected by non-lymphoid diseases. Mol Pathol 1998;51:333–338.
   PubMedGoogle Scholar
• Schmitt C, Balogh B, Grundt A, et al. The bcl-2/IgH rearrangement in a population of 204 healthy individuals: occurrence, age and gender distribution, breakpoints, and detection method validity. Leuk Res 2006;30:745–750.
   PubMed Web of Science ®Google Scholar
• Baccarelli A, Hirt C, Pesatori AC, et al. t(14;18) translocations in lymphocytes of healthy dioxin-exposed individuals from Seveso, Italy. Carcinogenesis 2006;27:2001–2007.
   PubMed Web of Science ®Google Scholar
• Alexander DD, Mink PJ, Adami HO, et al. The non-Hodgkin lymphomas: a review of the epidemiologic literature. Int J Cancer 2007;120(Suppl. 12):1–39.
   PubMed Web of Science ®Google Scholar
• Morton LM, Hartge P, Holford TR, et al. Cigarette smoking and risk of non-Hodgkin lymphoma: a pooled analysis from the International Lymphoma Epidemiology Consortium (interlymph). Cancer Epidemiol Biomarkers Prev 2005;14:925–933.
   PubMed Web of Science ®Google Scholar
• Parker AS, Cerhan JR, Dick F, et al. Smoking and risk of non-Hodgkin lymphoma subtypes in a cohort of older women. Leuk Lymphoma 2000;37:341–349.
   PubMed Web of Science ®Google Scholar
• Stagnaro E, Tumino R, Parodi S, et al. Non-Hodgkin's lymphoma and type of tobacco smoke. Cancer Epidemiol Biomarkers Prev 2004;13:431–437.
   PubMed Web of Science ®Google Scholar
• Chiu BC, Dave BJ, Blair A, et al. Cigarette smoking, familial hematopoietic cancer, hair dye use, and risk of t(14;18)-defined subtypes of non-Hodgkin's lymphoma. Am J Epidemiol 2007;165: 652–659.
   PubMed Web of Science ®Google Scholar
• Chang CM, Schroeder JC, Olshan AF, et al. A case-control study of tobacco use and other non-occupational risk factors for lymphoma subtypes defined by t(14;18) translocations and bcl-2 expression. Cancer Causes Control 2010;21:1147–1154.
   PubMed Web of Science ®Google Scholar
• Chang CM, Wang SS, Dave BJ, et al. Risk factors for non-Hodgkin lymphoma subtypes defined by histology and t(14;18) in a population-based case-control study. Int J Cancer 2011;129:938–947.
   PubMed Web of Science ®Google Scholar
• Schroeder JC, Olshan AF, Baric R, et al. A case-control study of tobacco use and other non-occupational risk factors for t(14;18) subtypes of non-Hodgkin's lymphoma (United States). Cancer Causes Control 2002;13:159–168.
   PubMed Web of Science ®Google Scholar
• Agopian J, Navarro JM, Gac AC, et al. Agricultural pesticide exposure and the molecular connection to lymphomagenesis. J Exp Med 2009;206:1473–1483.
   PubMed Web of Science ®Google Scholar
• Cramer DW, Finn OJ. Epidemiologic perspective on immune-surveillance in cancer. Curr Opin Immunol 2011;23:265–271.
   PubMed Web of Science ®Google Scholar
• Morton LM, Wang SS, Devesa SS, et al. Lymphoma incidence patterns by WHO subtype in the United States, 1992–2001. Blood 2006;107:265–276.
   PubMed Web of Science ®Google Scholar